Trinity Biotech secures US funding for HIV tests
DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, ...
ETF Daily News8d
Trinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.com
Trinity Biotech has a one year low of $0.74 and a ... sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus ...
ETF Daily News18d
Trinity Biotech (TRIB) Expected to Announce Quarterly Earnings on Wednesday
3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Trinity Biotech plc acquires ... diseases consisting of syphilis and herpes; SARS-CoV-2; and ...
Seeking Alpha17d
Trinity Biotech climbs after data for glucose monitoring device
Shares of Trinity Biotech (NASDAQ:TRIB) traded sharply higher on Tuesday after the Irish MedTech reported encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose ...
Nasdaq17d
Trinity Biotech Announces Promising Pre-Pivotal Trial Results for Next-Generation Continuous Glucose Monitoring System
Trinity Biotech plc has announced encouraging results from its recent pre-pivotal clinical trial of its next-generation continuous glucose monitoring (CGM) system, targeting diabetes management.
Business Insider17d
Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology
DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...